Skip to main content

MiRAVALVE-CKD

The ANR PRC project MiRAVALVE-CKD  - Mineralocorticoid Receptor Antagonism and Aortic Valve Calcification in Chronic Kidney Diseases , is an ANR PRC project (2024-2027), coordinated by Pr Frédéric Jaisser at the Centre de Recherche des Cordeliers , Inserm UMR S1138, in collaboration with Pr Paul Mulder, Inserm UMR1096 and Pr Natalia López-Andrés, Navarra University, Spain, is set to investigate the impact of the mineralocorticoid system in mediating valcular calcification in the setting of chronic kidney disease.

CITE-LYMPH

Dr Ebba Brakenhielm is Coordinator on an ANR international collaborative project entitled CITE-LYMPH : «Ciblage lymphatique cardiaque des cellules immunitaires» (ANR PRCI 2023-2026)  «Collaboration bilatérale ANR/ DFG»

This project is developed together with Pr Alma Zernecke-Madsen (Institut für Experimentelle Biomedizin der Universität Würzburg, Germany).

  • Team building in Wurzburg

  • Team in Rouen

  • Project over-view

  • Cardiac lymphatic valves

  • Publications

    Cardiac lymphatic clearance of fluids and immune cells may be reduced in heart failure. In a model of pressure-overload heart failure, we demonstrated, in an article published in EMBO Mol Med 2026, that myocardial inflammation alters lymphatic gene expression, which could limit fluid drainage, while lymphatic immune attraction profiles remain intact.

    • Myocardial inflammation reduces the expression of key lymphatic barrier genes (Cldn5 and Tjp1), thereby impairing lymphatic function.

    • Newly formed lymphatic capillaries lack valves, which further compromises directional fluid transport from the heart to the draining lymph nodes.

    • Lymphatic endothelial cells upregulate immune-modulatory genes (Ccl21 and Lyve1), which may partially compensate for the reduced flow by attracting more immune cells to the lymphatics.

    • Restoring lymphatic barrier integrity and valve formation are potential new therapeutic targets to improve myocardial fluid clearance, accelerate resolution of inflammation, and slow heart failure progression.

Read more …CITE-LYMPH

PHASM

 Pr Jeremy Bellien is Coordinator on an ANR international collaborative project entitled PHASM : «L'activité phosphatase de l'époxyde hydrolase soluble comme nouvelle cible dans les maladies cardiométaboliques» (ANR PRCI  2023-2026) «Collaboration bilatérale ANR/ DFG»

This project is developed together with  Pr Ewgeinj Proschak (Heisenberg-Professor for Drug Design at the Institut für Pharmazeutische Chemie, Goethe-Universität Frankfurt am Main, Germany).

POPHeart

Pr Paul Mulder is Partner on an ANR collaborative project entitled POPHeart : «Impact of pollutants and AHR signaling on cardiac function in predisposed models of cardiomyopathy»  (ANR PRC 2022-2026).

This project is coordinated by Dr Marianne Gervaise-Taurel (Inserm IMRB U955, Faculté de Médecine - UPEC) together with Dr Mathias Mericskay (Inserm U1180, Faculté de Pharmacie, Université Paris-Saclay).

In this project, our unit participate with evaluations of the cardiovascular impact of dioxine in animal models of metabolic syndrome.

Dioxines et leurs effets sur la santé (who.int)